Bio-Vent Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Bio-Vent General Information


Developer of an anti-influenza drug designed to target the viruses responsible for influenza. The company's drug is based on aptamers which are oligonucleotide or peptide molecules that bind to a specific target molecule, enabling healthcare providers to treat their patients and improve their lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Tzomet Abba Hillel
  • Yakhin Park
  • Ashkelon 7284
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Vent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC Completed Startup
To view Bio-Vent’s complete valuation and funding history, request access »